Ifeanyichukwu Ifechidere: DOAC Monitoring – What To Order, When, And Why
Ifeanyichukwu Ifechidere, Specialist Biomedical Scientist at Sheffield Teaching Hospitals NHS Foundation Trust, shared a post on LinkedIn:
“Not every patient on a DOAC needs monitoring.
But when they do, ordering the wrong assay can lead to the wrong clinical decision.
This is where many clinicians-and even laboratories-get caught out.
The question isn’t just ‘Should I measure the DOAC?’
It’s ‘Which assay answers my clinical question?’
Here’s a simple way to think about it:
- Anti-Xa assay
- Best for rivaroxaban, apixaban, and edoxaban
- Use a drug-specific calibrated Anti-Xa assay
- Helpful in major bleeding, urgent surgery, suspected overdose, renal impairment, or unexpected thrombosis.
Dilute Thrombin Time (dTT)
- Best for dabigatran
- Provides a quantitative estimate of dabigatran concentration.
- More reliable than routine clotting tests.
DOAC Screen
- Useful as a rapid screening tool to determine whether a clinically significant DOAC is present.
- Helpful in emergency settings when the anticoagulant history is uncertain.
- It is not a substitute for drug-specific quantification.
And here’s the part that’s often overlooked…
Timing matters just as much as assay selection.
A result is difficult to interpret unless you know:
- Which DOAC the patient is taking
- The dose
- The time of the last dose
- Renal function
- Whether you’re measuring a peak or trough level
Without that context, even the ‘right’ test can produce a misleading interpretation.
The takeaway:
The goal of DOAC testing isn’t simply to detect the drug.
It’s to answer a specific clinical question with the right assay at the right time.
What is the biggest challenge your laboratory or clinical team faces when interpreting DOAC assays?”

Find more posts featuring Ifeanyichukwu Ifechidere on Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026